ATA539376A - Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden - Google Patents

Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden

Info

Publication number
ATA539376A
ATA539376A AT539376A AT539376A ATA539376A AT A539376 A ATA539376 A AT A539376A AT 539376 A AT539376 A AT 539376A AT 539376 A AT539376 A AT 539376A AT A539376 A ATA539376 A AT A539376A
Authority
AT
Austria
Prior art keywords
fluoresteroids
9alpha
unsaturated
producing new
producing
Prior art date
Application number
AT539376A
Other languages
English (en)
Other versions
AT353989B (de
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ATA539376A publication Critical patent/ATA539376A/de
Application granted granted Critical
Publication of AT353989B publication Critical patent/AT353989B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT539376A 1975-07-23 1976-07-22 Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden AT353989B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH962075A CH611631A5 (en) 1975-07-23 1975-07-23 Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids

Publications (2)

Publication Number Publication Date
ATA539376A true ATA539376A (de) 1979-05-15
AT353989B AT353989B (de) 1979-12-10

Family

ID=4353884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT539376A AT353989B (de) 1975-07-23 1976-07-22 Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden

Country Status (15)

Country Link
JP (1) JPS5214761A (de)
AT (1) AT353989B (de)
AU (1) AU505846B2 (de)
BE (1) BE844378A (de)
CH (1) CH611631A5 (de)
DE (1) DE2632550A1 (de)
DK (1) DK329976A (de)
ES (1) ES449989A1 (de)
FR (1) FR2318644A1 (de)
GB (1) GB1520356A (de)
IE (1) IE43926B1 (de)
NL (1) NL7608141A (de)
NZ (1) NZ181538A (de)
SE (1) SE7608369L (de)
ZA (1) ZA764405B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5423643A (en) * 1977-07-22 1979-02-22 Aikawa Tekko Doctor blade stablizing apparatus
EP0029924B1 (de) * 1979-11-16 1984-08-15 STEROSYNT Ltd. 6-alpha-Fluoro-16-Methyl-prednisolon-17,21-diester und pharmazeutische Zusammensetzungen, die sie enthalten
FI911202A (fi) * 1990-12-28 1992-06-29 Albany Int Corp Schaberblad.

Also Published As

Publication number Publication date
NZ181538A (en) 1978-09-20
ES449989A1 (es) 1977-12-01
IE43926L (en) 1977-01-23
FR2318644B1 (de) 1978-12-15
AU505846B2 (en) 1979-12-06
BE844378A (fr) 1977-01-24
NL7608141A (nl) 1977-01-25
ZA764405B (en) 1977-08-31
FR2318644A1 (fr) 1977-02-18
IE43926B1 (en) 1981-07-01
GB1520356A (en) 1978-08-09
DE2632550A1 (de) 1977-02-10
SE7608369L (sv) 1977-01-24
DK329976A (da) 1977-01-24
AU1612176A (en) 1978-01-26
CH611631A5 (en) 1979-06-15
AT353989B (de) 1979-12-10
JPS5214761A (en) 1977-02-03

Similar Documents

Publication Publication Date Title
AT360663B (de) Verfahren zur herstellung von neuen 6,7- -benzomorphanen
AT366374B (de) Verfahren zur herstellung von neuen n3substituierten 5,5-dimethylhydantoinen
ATA81279A (de) Verfahren zur herstellung von neuen 9alpha,21- -dihalogen-11beta,17alpha-dihydroxy-6alpha- -fluor-16alpha-methyl-pregna-1,4-dien-3,20-dion -verbindungn
AT342045B (de) Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen
AT344896B (de) Verfahren zur herstellung von neuen piperazinyliminorifamycinen
AT349633B (de) Verfahren zur herstellung von neuen dauno- saminylanthracylcinonen
AT356671B (de) Verfahren zur herstellung von neuen n,n'-thio- -di-carbamaten
AT353956B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA585876A (de) Verfahren zur herstellung von neuen 2-benzimidazolylcarbamaten
AT354434B (de) Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen
AT341540B (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
ATA151379A (de) Verfahren zur herstellung von neuen 9alpha,21- dihalogen-11beta,17alpha-dihydroxy-6alpha-fluor -16beta-methyl-pregna-1,4-dien-verbindungen
ATA454376A (de) Verfahren zur herstellung von neuen 2,6-dinitro-3-azido-4-trifluormethylanilinen und -hydrazinen
AT345780B (de) Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril
AT344150B (de) Verfahren zur herstellung von neuen cyclohexylphenylen
AT353989B (de) Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden
AT358575B (de) Verfahren zur herstellung von neuen 2- carbalkoxyamino-5(6)-phenyl-sulfonyloxy- -benzimidazolen
DD129214A5 (de) Verfahren zur herstellung von neuen 1,9-dihydroxy-hexahydrodibenzopyranen
AT353759B (de) Verfahren zur herstellung von 1,2-dichloraethan
AT341669B (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
ATA418276A (de) Verfahren zur herstellung von neuen, substituierten 1,2,4-oxadiazolidin-3-on-verbindungen
AT345801B (de) Verfahren zur herstellung von neuen 1-phenoxy- 2-acyloxy-3-amino-propanderivaten
ATA491279A (de) Verfahren zur herstellung von neuen 2,9-alpha-
ATA81179A (de) Verfahren zur herstellung von neuen 9alpha, 21- -dihalogen-11beta, 17alpha-dihydroxy-6alpha- -fluor-16alpha-methyl-pregna-1,4-dien-3-20- -dion-verbindungen
AT347967B (de) Verfahren zur herstellung von neuen biguaniden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee